# OnCo record nct04864054 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04864054/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04864054", "NCT04864054" ;
  schema:name "GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC"@en ;
  schema:alternateName "ARYA-3"@en ;
  schema:description "A phase 1/2 trial of ECT204 T cells in hepatocellular carcinoma, run by Eureka Therapeutics Inc., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04864054/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04864054> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2022-03-11" ;
  onco:cancers <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/hcc-advanced/> ;
  onco:companies <https://onco.cc/companies/eureka-therapeutics/> .